ELOCTATE™ [Antihemophilic Factor (Recombinant), Fc Fusion Protein], is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A congenital factor VIII deficiency for:
- On-demand treatment and control of bleeding episodes
- Perioperative management of bleeding
- Routine prophylaxis to reduce the frequency of bleeding episodes
*ELOCTATE™ is not indicated for the treatment of von Willebrand disease.
For indications, dosing and other information, please refer to the prescribing information.